Monopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元

市场透视2024-10-25

北京时间2024年10月25日21时31分，Monopar Therapeutics Inc.（MNPR.us）股票出现异动，股价大幅跳水31.11%。截至发稿，该股报22.50美元/股，成交量64.5707万股，换手率18.34%，振幅1.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.72百万美元，每股收益-0.49美元，毛利0.00美元，市盈率-9.78倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2478925933?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-25 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2478925933","market":"us","top_or_hot":-1,"title":"Monopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月25日21时31分，Monopar Therapeutics Inc.（MNPR.us）股票出现异动，股价大幅跳水31.11%。截至发稿，该股报22.50美元/股，成交量64.5707万股，换手率18.34%，振幅1.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.72百万美元，每股收益-0.49美元，毛利0.00美元，市盈率-9.78倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Monopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMonopar Therapeutics Inc.股价重挫31.11% 市值跌2463.94万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-25 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月25日21时31分，Monopar Therapeutics Inc.（MNPR.us）股票出现异动，股价大幅跳水31.11%。截至发稿，该股报22.50美元/股，成交量64.5707万股，换手率18.34%，振幅1.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.72百万美元，每股收益-0.49美元，毛利0.00美元，市盈率-9.78倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNPR","symbol_name":"Monopar Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b","article_id":"2478925933","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521310495bd589a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2478925933","pubTimestamp":1729863064,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月25日21时31分，Monopar Therapeutics Inc.股票出现异动，股价大幅跳水31.11%。截至发稿，该股报22.50美元/股，成交量64.5707万股，换手率18.34%，振幅1.96%。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MNPR":"Monopar Therapeutics","BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Monopar Therapeutics Inc. 's stock plunges 31.11%, its market value falls by $24.6394 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"MNPR":1},"content_text":"北京时间2024年10月25日21时31分，Monopar Therapeutics Inc.（MNPR.us）股票出现异动，股价大幅跳水31.11%。截至发稿，该股报22.50美元/股，成交量64.5707万股，换手率18.34%，振幅1.96%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.72百万美元，每股收益-0.49美元，毛利0.00美元，市盈率-9.78倍。机构评级方面，在所有4家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Monopar Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Elevai Labs, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029(To Pur Com)、180 Life Sciences Corp.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为447.76%、279.48%、22.77%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 (To Pur Com)、180 Life Sciences Corp.、Elevai Labs, Inc.，振幅分别为66.85%、20.62%、18.76%。Monopar Therapeutics Inc.公司简介：Monopar Therapeutics Inc 是一家临床阶段的生物制药公司，专注于开发旨在延长癌症患者生命或提高生活质量的专有疗法。 该公司的产品线包括用于预防口咽癌患者放化疗引起的严重口腔粘膜炎的 Validive、用于治疗软组织肉瘤的 camsirubicin、用于治疗癌症和重症 COVID-19 的晚期临床前抗体 MNPR-101，以及用于治疗各种癌症的早期卡西鲁比星类似物 MNPR-202。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2478925933"}